

CLASSIFICATION: WAKEFULNESS-PROMOTING AGENT (EUGEROIC)
ACTIVE SUBSTANCE: MODAFINIL
FORM: 30 TABLETS x 200 MG
ACTIVE HALF-LIFE: ~12–15 HOURS
DOSAGE: MEN 200 MG ONCE DAILY
ACNE: NOT TYPICAL
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): MAY INCREASE HR/BP
HEPATOTOXICITY: RARE
AROMATIZATION: NONE
MANUFACTURER: GENVEON
Modiwake delivers modafinil, a wakefulness-promoting agent (eugeroic) used under prescription for conditions such as narcolepsy, obstructive sleep apnea–related residual sleepiness, and shift-work sleep disorder. Unlike classic psychostimulants, modafinil's clinical profile is characterized by enhanced wakefulness with comparatively lower rates of sympathomimetic side effects in many patients—yet it remains an RX-only medicine that must be used with clinician oversight.
High-output training blocks, contest prep, travel, and shift work can challenge sleep architecture and daytime alertness. When a licensed clinician diagnoses a qualifying sleep–wake disorder, modafinil may help restore functional wakefulness so you can execute your plan—programming, nutrition, and recovery—more consistently. It is not a pre-workout nor a replacement for sleep. Smart use means: medical evaluation, daytime scheduling (to protect nighttime sleep), and monitoring of blood pressure, heart rate, mood, and liver function when clinically indicated.
Modafinil's mechanism is multifactorial. It weakly inhibits the dopamine transporter (DAT) and influences norepinephrine signaling, while also modulating glutamatergic/GABAergic pathways and orexin/hypocretin systems involved in arousal and circadian stability. The net result is heightened wakefulness and vigilance with typically modest effects on peripheral sympathomimetic markers compared with classic stimulants. Sensitivity varies—some users experience pronounced alertness, others a smoother "anti-fatigue" effect.
Typical adult dosing is 200 mg once daily in the morning. Some patients respond to 100 mg; others may require divided dosing (e.g., 100 mg AM + 100 mg midday) as prescribed. In hepatic impairment, clinicians usually reduce the dose by half. Because modafinil can interact with other medications (notably by inducing CYP3A4 and inhibiting CYP2C19), dosing must be individualized and reviewed whenever your regimen changes.
Most users tolerate modafinil, but important risks exist. Report rash immediately—rare but serious dermatologic reactions (e.g., SJS/TEN) have been associated with modafinil. Psychiatric effects (anxiety, irritability, agitation), headache, nausea, dizziness, and insomnia are among commonly reported adverse events. Blood pressure and heart rate can rise; individuals with cardiovascular disease or arrhythmia require extra caution. Modafinil may reduce the effectiveness of hormonal contraceptives (enzyme induction)—use a backup method during therapy and for a period after discontinuation per clinician advice.
Think of Modiwake as support for healthy wakefulness—your results still come from progressive overload, sufficient calories/protein (often 1.6–2.2 g/kg/day), and 7–9 hours of sleep. Practical tips:
Modafinil is prohibited in-competition under many anti-doping codes (e.g., WADA) as a stimulant-class substance. Athletes subject to testing must consult their governing body and physician about Therapeutic Use Exemptions (TUEs) and regional rules. Always verify the current status before sanctioned events.
For FDA-vetted, patient-friendly details on modafinil's indications, precautions, and interactions, see MedlinePlus: Modafinil. Your clinician will tailor dose, timing, and monitoring to your health profile and training schedule.
Consider these Dragon Pharma products frequently discussed with clinicians to support focus, stress management, and sleep—not substitutes for prescription therapy:
This listing is for genuine Genveon Modiwake 200 mg tablets, pack of 30. Store at room temperature, away from moisture and heat. Keep out of reach of children. Use only if prescribed and sourced legally in your jurisdiction. We ship discreetly within the USA with secure checkout.
Medical & legal disclaimer: Informational content only—not medical advice. Use prescription medicines solely under a licensed clinician's supervision and according to local laws.
Most users feel effects within 30–90 minutes. Wakefulness typically lasts through the workday; the half-life is about 12–15 hours, so avoid late dosing to protect sleep.
Modafinil promotes wakefulness with a distinct mechanism and generally milder sympathomimetic effects, but it still carries risks and interactions and requires a prescription and monitoring.
Use caution. Stimulant-heavy products (caffeine, yohimbine, synephrine) can increase side effects like anxiety, elevated HR/BP, and insomnia. Coordinate your stack with your clinician before combining.
Yes. Modafinil can reduce effectiveness of hormonal contraceptives. Use non-hormonal backup during therapy and for a period after stopping, per clinician guidance.
Often no. Modafinil is typically prohibited in-competition under anti-doping rules (e.g., WADA). Check current rules and discuss Therapeutic Use Exemptions with your physician and federation.
Please log in to write MODIWAKE 200 MG review.
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 100 PILLS x 1 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 1 MG EACH OTHER DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: SERM; PROGONADOTROPIN
ACTIVE SUBSTANCE: CLOMIPHENE CITRATE
FORM: 100 PILLS x 50 MG
ACTIVE HALF-LIFE: 5-7 DAYS
DOSAGE: MEN 25-150 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: VERY LOW
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 100 PILLS x 25 MG
ACTIVE HALF-LIFE: 9 HOURS
DOSAGE: MEN 12.5-25 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 100 PILLS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 0.5-2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
SELECTIVE ESTROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 5 DAYS
DOSAGE: MEN 20-120 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: VERY LOW
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 30 PILLS x 1 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: MEN 1 MG EACH OTHER DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
SELECTIVE ESTROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: TOREMIFENE CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 5 DAYS
DOSAGE: MEN 20-120 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: VERY LOW
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
CLASS: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 30 PILLS x 25 MG
ACTIVE HALF-LIFE: 24 HOURS
DOSAGE: 25 MG/DAY WITH MEALS
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED
MANUFACTURER: KALPA PHARMACEUTICALS